Ozempic is a brand name semaglutide, a medication used to treat type 2 diabetes. It’s also used as an off-label use for weight loss. Wegovy is another brand name with the same a ...

Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Although it is best known for treating type 2 diabetes, semaglutide — known by its brandname Ozempic — may also be effective ...

Ozempic is approved for type 2 diabetes, while its counterpart, Wegovy, is approved for treating obesity. Both are made by Novo Nordisk. Eli Lilly also offers a diabetes medication, Mounjaro ...

Obese adults who took the weekly injection lost up to 22% of their starting weight after 11 months — compared to just 14% over 15 months for semaglutide, the active ingredient in Ozempic and Wegovy.

“Ozempic is a medication that has been used in the past to treat type 2 diabetes, which is actually insulin resistance,” said Dr. Michelle Owens, a medical expert at Healthy Solutions Clinic ...

President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.

A first randomized clinical trial shows that semaglutide use in type 1 diabetes is associated with improved glucose ...

For example, some insurance covers Ozempic for prediabetes, and other times insurance will only cover Ozempic if you already have Type 2 diabetes. Ozempic is more likely to be covered by insurance if ...